TVPills

Novartis Drugs Advertised on TV

5 prescription medications from Novartis seen in TV advertising, with an estimated $480M in combined annual ad spend. Ranked by ad spend.

Share
US Cosentyx

secukinumab · Plaque psoriasis, psoriatic arthritis, ankylosing spondylitis

$160M CostDetails
US Entresto

sacubitril/valsartan · Chronic heart failure

$150M CostDetails
US Leqvio

inclisiran · High cholesterol, cardiovascular disease

$90M CostDetails
US Kisqali

ribociclib · HR-positive, HER2-negative breast cancer

$80M CostDetails
US Kesimpta

ofatumumab · Multiple sclerosis

— CostDetails

Frequently asked questions

What drugs does Novartis advertise on TV?

Cosentyx, Entresto, Leqvio, Kisqali, Kesimpta are among the Novartis medications TVPills tracks in TV advertising — 5 in total.

Which Novartis drug spends the most on TV advertising?

Cosentyx (secukinumab) leads Novartis's TV-advertised lineup with an estimated $160M in annual ad spend.

What conditions do Novartis drugs treat?

The Novartis drugs we track are advertised for Autoimmune, Cardiovascular, Oncology, Neurology.

Is a Novartis drug right for me?

TVPills is an informational reference, not medical advice. Only a licensed healthcare provider can recommend whether a Novartis medication is right for your situation.

TVPills

A reference tool to help identify prescription medications and supplements seen in television advertising. This is not medical advice. Always consult a healthcare professional.

TVPills is independent and not affiliated with, endorsed by, or sponsored by any drug manufacturer or brand. All trademarks are the property of their respective owners. Some links are affiliate links; we may earn a commission at no extra cost to you.